IHS Chemical Week

Regions :: North America :: U.S.

Bayer to acquire birth control firm Conceptus for $1.1 billion

7:01 AM MDT | April 29, 2013 | Natasha Alperowicz

Bayer HealthCare has signed a merger agreement with Conceptus (Mountain View; CA), the developer of the Essure procedure—a leading nonsurgical, permanent birth-control method, Bayer announced today. The move aims to broaden Bayer’s portfolio in the field of contraception. Bayer, following the acquisition, will be able to offer a complete range of short-term, long-term, and permanent contraceptive choices for women, the company says.     Bayer will launch a public tender offer to acquire all shares in Conceptus within the next...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa